Increased Levels of sRAGE in Diabetic CKD-G5D Patients: A Potential Protective Mechanism against AGE-Related Upregulation of Fibroblast Growth Factor 23 and Inflammation

Advanced glycation end products (AGEs) may induce cardiac remodeling in kidney disease by promoting fibroblast growth factor 23 (FGF-23) expression. Since AGEs are increased in diabetes mellitus (DM), our first aim was to evaluate the existence of any potential association between AGEs, FGF-23, infl...

Full description

Saved in:
Bibliographic Details
Main Authors: Elena Dozio, Valentina Corradi, Elena Vianello, Elisa Scalzotto, Massimo de Cal, Massimiliano Marco Corsi Romanelli, Claudio Ronco
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2017/9845175
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849467403267735552
author Elena Dozio
Valentina Corradi
Elena Vianello
Elisa Scalzotto
Massimo de Cal
Massimiliano Marco Corsi Romanelli
Claudio Ronco
author_facet Elena Dozio
Valentina Corradi
Elena Vianello
Elisa Scalzotto
Massimo de Cal
Massimiliano Marco Corsi Romanelli
Claudio Ronco
author_sort Elena Dozio
collection DOAJ
description Advanced glycation end products (AGEs) may induce cardiac remodeling in kidney disease by promoting fibroblast growth factor 23 (FGF-23) expression. Since AGEs are increased in diabetes mellitus (DM), our first aim was to evaluate the existence of any potential association between AGEs, FGF-23, inflammation, and increased cardiovascular risk in DM patients on dialysis (CKD-G5D). Secondarily, we explored the potential role of the soluble receptor for AGEs (sRAGE) as a marker of heart failure. Levels of glycated albumin (GA), sRAGE, c-terminal FGF-23 (cFGF-23), brain natriuretic peptide (BNP), and inflammatory mediators were compared between DM and non-DM CKD-G5D patients. The levels of sRAGE, cFGF-23, BNP, and proinflammatory markers were over the ranges of normality in both DM and non-DM groups. Only GA and sRAGE levels were increased in DM compared to non-DM patients. Plasma levels of sRAGE and CRP were the only independent predictors of BNP concentration. In conclusion, in DM CKD-G5D patients, sRAGE appeared to be a marker of cardiac remodeling. Indeed, its increase could be a potential protective mechanism against the increased risk of cardiovascular complications related to AGEs and inflammation. The causal relationship between sRAGE and cardiovascular risk in these patients needs to be further confirmed by mechanistic studies.
format Article
id doaj-art-dee9663c72a246e2a99fb9d6ffa826c0
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-dee9663c72a246e2a99fb9d6ffa826c02025-08-20T03:26:15ZengWileyMediators of Inflammation0962-93511466-18612017-01-01201710.1155/2017/98451759845175Increased Levels of sRAGE in Diabetic CKD-G5D Patients: A Potential Protective Mechanism against AGE-Related Upregulation of Fibroblast Growth Factor 23 and InflammationElena Dozio0Valentina Corradi1Elena Vianello2Elisa Scalzotto3Massimo de Cal4Massimiliano Marco Corsi Romanelli5Claudio Ronco6Department of Biomedical Sciences for Health, Università degli Studi di Milano, Via L. Mangiagalli 31, 20133 Milan, ItalyDepartment of Nephrology, Dialysis and Transplantation, San Bortolo Hospital, Viale Rodolfi 37, 36100 Vicenza, ItalyDepartment of Biomedical Sciences for Health, Università degli Studi di Milano, Via L. Mangiagalli 31, 20133 Milan, ItalyInternational Renal Research Institute Vicenza (IRRIV), San Bortolo Hospital, Viale Rodolfi 37, 36100 Vicenza, ItalyDepartment of Nephrology, Dialysis and Transplantation, San Bortolo Hospital, Viale Rodolfi 37, 36100 Vicenza, ItalyDepartment of Biomedical Sciences for Health, Università degli Studi di Milano, Via L. Mangiagalli 31, 20133 Milan, ItalyDepartment of Nephrology, Dialysis and Transplantation, San Bortolo Hospital, Viale Rodolfi 37, 36100 Vicenza, ItalyAdvanced glycation end products (AGEs) may induce cardiac remodeling in kidney disease by promoting fibroblast growth factor 23 (FGF-23) expression. Since AGEs are increased in diabetes mellitus (DM), our first aim was to evaluate the existence of any potential association between AGEs, FGF-23, inflammation, and increased cardiovascular risk in DM patients on dialysis (CKD-G5D). Secondarily, we explored the potential role of the soluble receptor for AGEs (sRAGE) as a marker of heart failure. Levels of glycated albumin (GA), sRAGE, c-terminal FGF-23 (cFGF-23), brain natriuretic peptide (BNP), and inflammatory mediators were compared between DM and non-DM CKD-G5D patients. The levels of sRAGE, cFGF-23, BNP, and proinflammatory markers were over the ranges of normality in both DM and non-DM groups. Only GA and sRAGE levels were increased in DM compared to non-DM patients. Plasma levels of sRAGE and CRP were the only independent predictors of BNP concentration. In conclusion, in DM CKD-G5D patients, sRAGE appeared to be a marker of cardiac remodeling. Indeed, its increase could be a potential protective mechanism against the increased risk of cardiovascular complications related to AGEs and inflammation. The causal relationship between sRAGE and cardiovascular risk in these patients needs to be further confirmed by mechanistic studies.http://dx.doi.org/10.1155/2017/9845175
spellingShingle Elena Dozio
Valentina Corradi
Elena Vianello
Elisa Scalzotto
Massimo de Cal
Massimiliano Marco Corsi Romanelli
Claudio Ronco
Increased Levels of sRAGE in Diabetic CKD-G5D Patients: A Potential Protective Mechanism against AGE-Related Upregulation of Fibroblast Growth Factor 23 and Inflammation
Mediators of Inflammation
title Increased Levels of sRAGE in Diabetic CKD-G5D Patients: A Potential Protective Mechanism against AGE-Related Upregulation of Fibroblast Growth Factor 23 and Inflammation
title_full Increased Levels of sRAGE in Diabetic CKD-G5D Patients: A Potential Protective Mechanism against AGE-Related Upregulation of Fibroblast Growth Factor 23 and Inflammation
title_fullStr Increased Levels of sRAGE in Diabetic CKD-G5D Patients: A Potential Protective Mechanism against AGE-Related Upregulation of Fibroblast Growth Factor 23 and Inflammation
title_full_unstemmed Increased Levels of sRAGE in Diabetic CKD-G5D Patients: A Potential Protective Mechanism against AGE-Related Upregulation of Fibroblast Growth Factor 23 and Inflammation
title_short Increased Levels of sRAGE in Diabetic CKD-G5D Patients: A Potential Protective Mechanism against AGE-Related Upregulation of Fibroblast Growth Factor 23 and Inflammation
title_sort increased levels of srage in diabetic ckd g5d patients a potential protective mechanism against age related upregulation of fibroblast growth factor 23 and inflammation
url http://dx.doi.org/10.1155/2017/9845175
work_keys_str_mv AT elenadozio increasedlevelsofsrageindiabeticckdg5dpatientsapotentialprotectivemechanismagainstagerelatedupregulationoffibroblastgrowthfactor23andinflammation
AT valentinacorradi increasedlevelsofsrageindiabeticckdg5dpatientsapotentialprotectivemechanismagainstagerelatedupregulationoffibroblastgrowthfactor23andinflammation
AT elenavianello increasedlevelsofsrageindiabeticckdg5dpatientsapotentialprotectivemechanismagainstagerelatedupregulationoffibroblastgrowthfactor23andinflammation
AT elisascalzotto increasedlevelsofsrageindiabeticckdg5dpatientsapotentialprotectivemechanismagainstagerelatedupregulationoffibroblastgrowthfactor23andinflammation
AT massimodecal increasedlevelsofsrageindiabeticckdg5dpatientsapotentialprotectivemechanismagainstagerelatedupregulationoffibroblastgrowthfactor23andinflammation
AT massimilianomarcocorsiromanelli increasedlevelsofsrageindiabeticckdg5dpatientsapotentialprotectivemechanismagainstagerelatedupregulationoffibroblastgrowthfactor23andinflammation
AT claudioronco increasedlevelsofsrageindiabeticckdg5dpatientsapotentialprotectivemechanismagainstagerelatedupregulationoffibroblastgrowthfactor23andinflammation